Associate Professor David Greening has been appointed Director of La Trobe University’s proteomics and metabolomics platform.
Associate Professor Greening was Capability Manager of La Trobe’s proteomics platform for five years, prior to joining the Baker Heart and Diabetes Institute as Head of molecular proteomics and metabolomics research platform.
He has an outstanding record of achievement and leadership in quantitative proteomics, mass spectrometry, cell biology and signalling, cellular reprogramming and cell-derived extracellular vesicles.
Associate Professor Greening’s appointment further strengthens the partnership between La Trobe and the Baker Institute, which was consolidated in 2021 with the establishment of the Baker Department of Cardiovascular Research, Translation and Implementation.
“Mass spectrometry-based proteomics and metabolomics are critical tools for applied, clinical and translational research. Such technological advances provide key insights into the molecular basis of how cells and tissues function,” Associate Professor Greening says.
“I’m excited to develop further collaborations in this space within and across academia, medical research, and industry partners.”
About the proteomics and metabolomics platform
La Trobe’s proteomics and metabolomics platform offers a suite of capabilities for the characterisation of proteins and metabolites of interest to academic and industry researchers in the agricultural, health, life, molecular, pharmaceutical, population, and psychological sciences.
The platform enables the identification and quantitation of biomolecules, from complex mixtures through to metabolomics and small molecule structure determination.
Core expertise in advanced experimental design, informatics and data analysis underpins the main capabilities of the platform.
“Our facilities feature a diverse portfolio of different high resolution mass spectrometers, across both sites at AgriBio and La Trobe Institute for Molecular Science,” explains Associate Professor Greening.
“With over 50 years of combined expertise, workflow of capabilities enable the identification and quantitation of biomolecules from complex mixtures through to metabolomics and small molecule structure determination.”